跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EDOXABAN TAD 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
EDOXABAN TAD 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
EDOXABAN TAD 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Tad Pharma Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 29, 2025
Approval ID
307a15b2690eefbf
Company
Tad Pharma Gmbh
Type
Standard
Approval Details
Approval Id
307a15b2690eefbf
Drug Cima Aemps Name
EDOXABAN TAD 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
90099
Holder Company Name
Tad Pharma Gmbh
Marketing Company Name
Krka Farmaceutica S.L.
Holder Company Detail Path
/organization/tad-pharma-gmbh
Authorization Date
2025-01-29
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
15 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Tad Pharma Gmbh
Company Detail Path
/organization/tad-pharma-gmbh
Company Information
Pharmaceutical Company Name
TAD Pharma GmbH
Country Name
Germany
City Name
cuxhaven,niedersachsen,country_de
Address
Heinz-Lohmann-Str. 5
Active Ingredients
EDOXABAN TOSILATO MONOHIDRATO
20,20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 29, 2025
Approval ID
307a15b2690eefbf
Type
Standard
Back to CIMA-AEMPS Approvals